Form 4: Entrada Therapeutics' Chief Scientific Officer Sells Shares
SEC Form 4 Filing
Natarajan Sethuraman, Chief Scientific Officer of Entrada Therapeutics, sold a portion of his holdings in two transactions on September 6 and September 9, 2024, under a pre-arranged trading plan.
Summary
- Natarajan Sethuraman, the Chief Scientific Officer of Entrada Therapeutics, sold shares of common stock on September 6 and September 9, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on December 14, 2023.
- On September 6, 2024, 600 shares were sold at a weighted average price of $15.2356, with prices ranging from $15.08 to $15.45.
- On September 9, 2024, 2,642 shares were sold at a weighted average price of $15.0879, with prices ranging from $15.00 to $15.25.
- Following these transactions, Sethuraman directly owns 183,816 shares of Entrada Therapeutics.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions were pre-planned under a Rule 10b5-1 trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Insider selling can be interpreted in various ways by the market. It's important to consider the context, such as the existence of a pre-arranged trading plan, to understand the motivations behind the transactions. Rule 10b5-1 plans are often used to avoid accusations of trading on inside information.
Stakeholder Impact
- Shareholders may react to insider selling, although the existence of a pre-arranged trading plan mitigates potential negative interpretations.
Key Dates
| Date | Description |
|---|---|
| 2023-12-14 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-09-06 | Date of first stock sale |
| 2024-09-09 | Date of second stock sale |
| 2024-09-10 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.